Tel Aviv / Zurich, 11 August 2017 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY)
(“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced that
it has been informed by the Swiss Takeover Board of an application and complaint of Nehama & Yoram
Alroy Investment Ltd. and Elon Shalev regarding the potential duty of Himalaya (Cayman Island) TMT
Fund and/or Himalaya Asset Management Ltd. and/or Mr. Xu Xiang and/or GF Fund Management Co.
Ltd. and/or Zhuhai Hokai Medical Instruments Co. Ltd. and/or Mrs. Cai Mengke to make a mandatory
tender offer according to art. 135 of the Swiss Financial Market Infrastructure Act. The applicants of the
application and complaint claim the share price of such potential mandatory tender offer to be CHF 8.70
For more information Click here
- About Us
- Solutions & Products
- How Does It Work?
- Contact Us